The DOI matches its Crossref record; 151 of the 151 references it cites were found in a registry or an index.
Natural products as multidrug resistance modulators in cancer
Open accessAbstract
Cancer is a prominent cause of death globally. Currently, many drugs that are in clinical practice are having a high prevalence of side effect and multidrug resistance. Risk of tumors acquiring resistance to chemotherapy (multidrug resistance) remains a significant hurdle to the successful treatment of various types of cancer. Membrane-embedded drug transporters, generally overexpressed in cancer, are the leading cause among multiple mechanisms of multidrug resistance (MDR). P-glycoprotein (P-gp) also MDR1/ABCB1, multidrug resistance associated protein 1 (MRP1/ABCC1), MRP2 and breast cancer resistance protein (BCRP/ABCG2) are considered to be a prime factor for induction of MDR. To date, several chemical substances have been tested in a number of clinical trials for their MDR modulatory activity which are not having devoid of any side effects that necessitates to find newer and safer way to tackle the current problem of multidrug resistance in cancer. The present study systematically discusses the various classes of natural products i.e flavonoids, alkaloids, terpenoids, coumarins (from plants, marine, and microorganisms) as potential MDR modulators and/or as a source of promising lead compounds. Recently a bisbenzyl isoquinoline alkaloid namely tetrandrine, isolated from Chinese herb Stephania tetrandra (Han-Fang-Chi) is in clinical trials for its MDR reversal activity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109
Panche, A. N., Diwan, A. D., & Chandra, S. R. (2016) · Journal of Nutritional Science · doi:10.1017/jns.2016.41 · Cited by 5,298
Tumour heterogeneity and resistance to cancer therapies
Dagogo-Jack, I., & Shaw, A. T. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2017.166 · Cited by 3,846
Targeting multidrug resistance in cancer
Szakács, G., Paterson, J. K., Ludwig, J. A., Booth-Genthe, C., & Gottesman, M. M. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1984 · Cited by 3,609
A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants
Juliano, R. L., & Ling, V. (1976) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(76)90160-7 · Cited by 3,296
Overexpression of a Transporter Gene in a Multidrug-Resistant Human Lung Cancer Cell Line
Cole, S. P. C., Bhardwaj, G., Gerlach, J. H., Mackie, J. E., Grant, C. E., Almquist, K. C., Stewart, A. J., Kurz, E. U., Duncan, A. M. V., & Deeley, R. G. (1992) · Science · doi:10.1126/science.1360704 · Cited by 3,037
Discovery and resupply of pharmacologically active plant-derived natural products: A review
Atanasov, A. G., Waltenberger, B., Pferschy-Wenzig, E.-M., Linder, T., Wawrosch, C., Uhrin, P., Temml, V., Wang, L., Schwaiger, S., Heiss, E. H., et al. (2015) · Biotechnology Advances · doi:10.1016/j.biotechadv.2015.08.001 · Cited by 2,904
The biochemistry and medical significance of the flavonoids
Havsteen, B. H. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00298-x · Cited by 2,672
A multidrug resistance transporter from human MCF-7 breast cancer cells
Doyle, L. A., Yang, W., Abruzzo, L. V., Krogmann, T., Gao, Y., Rishi, A. K., & Ross, D. D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15665 · Cited by 2,322
Drug Resistance and the Solid Tumor Microenvironment
Tredan, O., Galmarini, C. M., Patel, K., & Tannock, I. F. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djm135 · Cited by 2,116
Flavonoids: biosynthesis, biological functions, and biotechnological applications
Falcone Ferreyra, M. L., Rius, S. P., & Casati, P. (2012) · Frontiers in Plant Science · doi:10.3389/fpls.2012.00222 · Cited by 1,831
Leslie, E. M., Deeley, R. G., & Cole, S. P. C. (2005) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2004.10.012 · Cited by 1,406
Impact of Natural Products on Developing New Anti-Cancer Agents
Cragg, G. M., Grothaus, P. G., & Newman, D. J. (2009) · Chemical Reviews · doi:10.1021/cr900019j · Cited by 1,302
Thomas, H., & Coley, H. M. (2003) · Cancer Control · doi:10.1177/107327480301000207 · Cited by 931
Natural products: An evolving role in future drug discovery
Mishra, B. B., & Tiwari, V. K. (2011) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2011.07.057 · Cited by 860
Kathawala, R. J., Gupta, P., Ashby, C. R., & Chen, Z.-S. (2015) · Drug Resistance Updates · doi:10.1016/j.drup.2014.11.002 · Cited by 777
Nanomedicine therapeutic approaches to overcome cancer drug resistance
Markman, J. L., Rekechenetskiy, A., Holler, E., & Ljubimova, J. Y. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.09.019 · Cited by 733
Chen, Z., Shi, T., Zhang, L., Zhu, P., Deng, M., Huang, C., Hu, T., Jiang, L., & Li, J. (2016) · Cancer Letters · doi:10.1016/j.canlet.2015.10.010 · Cited by 729
Sarkadi, B., Homolya, L., Szakács, G., & Váradi, A. (2006) · Physiological Reviews · doi:10.1152/physrev.00037.2005 · Cited by 726
From bench to clinic with apoptosis-based therapeutic agents
Nicholson, D. W. (2000) · Nature · doi:10.1038/35037747 · Cited by 687
Mechanisms of Multidrug Resistance in Cancer
Gillet, J.-P., & Gottesman, M. M. (2010) · Methods in Molecular Biology · doi:10.1007/978-1-60761-416-6_4 · Cited by 685
Li, W., Zhang, H., Assaraf, Y. G., Zhao, K., Xu, X., Xie, J., Yang, D.-H., & Chen, Z.-S. (2016) · Drug Resistance Updates · doi:10.1016/j.drup.2016.05.001 · Cited by 673
The odyssey of marine pharmaceuticals: a current pipeline perspective
Mayer, A. M. S., Glaser, K. B., Cuevas, C., Jacobs, R. S., Kem, W., Little, R. D., McIntosh, J. M., Newman, D. J., Potts, B. C., & Shuster, D. E. (2010) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2010.02.005 · Cited by 666
Autophagy and multidrug resistance in cancer
Li, Y.-J., Lei, Y.-H., Yao, N., Wang, C.-R., Hu, N., Ye, W.-C., Zhang, D.-M., & Chen, Z.-S. (2017) · Chinese Journal of Cancer · doi:10.1186/s40880-017-0219-2 · Cited by 665
Büchler, M., König, J., Brom, M., Kartenbeck, J., Spring, H., Horie, T., & Keppler, D. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.25.15091 · Cited by 638
Structure and mechanism of ABC transporters
Wilkens, S. (2015) · F1000Prime Reports · doi:10.12703/p7-14 · Cited by 591
Ferreira, J. F. S., Luthria, D. L., Sasaki, T., & Heyerick, A. (2010) · Molecules · doi:10.3390/molecules15053135 · Cited by 531
Hyafil, F., Pauwels-Vergely, C., Vignaud, P. D., & Grand‐Perret, T. (1993) · PubMed · Cited by 525
Three Decades of P-gp Inhibitors: Skimming Through Several Generations and Scaffolds
Palmeira, A., Sousa, E., H. Vasconcelos, M., & M. Pinto, M. (2012) · Current Medicinal Chemistry · doi:10.2174/092986712800167392 · Cited by 484
Lysosomes as mediators of drug resistance in cancer
Zhitomirsky, B., & Assaraf, Y. G. (2016) · Drug Resistance Updates · doi:10.1016/j.drup.2015.11.004 · Cited by 482
Kruijtzer, C. M. F., Beijnen, J. H., Rosing, H., ten Bokkel Huinink, W. W., Schot, M., Jewell, R. C., Paul, E. M., & Schellens, J. H. M. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.12.116 · Cited by 464
Molecular structure of human P-glycoprotein in the ATP-bound, outward-facing conformation
Kim, Y., & Chen, J. (2018) · Science · doi:10.1126/science.aar7389 · Cited by 456
Comprehensive Natural Products II
(2010) · Elsevier eBooks · doi:10.1016/c2009-1-28362-6 · Cited by 454
P-glycoprotein inhibitors and their screening: a perspective from bioavailability enhancement
Varma, M. (2003) · Pharmacological Research · doi:10.1016/s1043-6618(03)00158-0 · Cited by 418
The apical conjugate efflux pump ABCC2 (MRP2)
Nies, A. T., & Keppler, D. (2007) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-006-0109-y · Cited by 398
Anticancer Drugs from Marine Flora: An Overview
Sithranga Boopathy, N., & Kathiresan, K. (2010) · Journal of Oncology · doi:10.1155/2010/214186 · Cited by 394
Pharmacological Strategies for Overcoming Multidrug Resistance
Nobili, S., Landini, I., Giglioni, B., & Mini, E. (2006) · Current Drug Targets · doi:10.2174/138945006777709593 · Cited by 393
Structural Basis of Substrate Recognition by the Multidrug Resistance Protein MRP1
Johnson, Z. L., & Chen, J. (2017) · Cell · doi:10.1016/j.cell.2017.01.041 · Cited by 375
Flavonoids Are Inhibitors of Breast Cancer Resistance Protein (ABCG2)-Mediated Transport
Zhang, S., Yang, X., & Morris, M. E. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.5.1208 · Cited by 359
Drug Transporters in Drug Efficacy and Toxicity
DeGorter, M. K., Xia, C. Q., Yang, J. J., & Kim, R. B. (2012) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010611-134529 · Cited by 359
(2001) · PubMed · Cited by 350
Tariquidar (XR9576): a P-glycoprotein drug efflux pump inhibitor
Fox, E., & Bates, S. E. (2007) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.7.4.447 · Cited by 350
Molecular mechanisms of drug resistance and its reversal in cancer
Kartal-Yandim, M., Adan-Gokbulut, A., & Baran, Y. (2016) · Critical Reviews in Biotechnology · doi:10.3109/07388551.2015.1015957 · Cited by 346
Modulation of P-glycoprotein efflux pump: induction and activation as a therapeutic strategy
Silva, R., Vilas-Boas, V., Carmo, H., Dinis-Oliveira, R. J., Carvalho, F., de Lourdes Bastos, M., & Remião, F. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.11.013 · Cited by 339
Structure and Function of ABC Transporters
Linton, K. J. (2007) · Physiology · doi:10.1152/physiol.00046.2006 · Cited by 329
Dantzig, A. H., Shepard, R. L., Cao, J., Law, K. L., Ehlhardt, W. J., Baughman, T. M., Bumol, T. F., & Starling, J. J. (1996) · PubMed · Cited by 328
Structural basis of small-molecule inhibition of human multidrug transporter ABCG2
Jackson, S. M., Manolaridis, I., Kowal, J., Zechner, M., Taylor, N. M. I., Bause, M., Bauer, S., Bartholomaeus, R., Bernhardt, G., Koenig, B., et al. (2018) · Nature Structural & Molecular Biology · doi:10.1038/s41594-018-0049-1 · Cited by 321
P-glycoprotein inhibitors of natural origin as potential tumor chemo-sensitizers: A review
Abdallah, H. M., Al-Abd, A. M., El-Dine, R. S., & El-Halawany, A. M. (2015) · Journal of Advanced Research · doi:10.1016/j.jare.2014.11.008 · Cited by 319
Targeting Multidrug Resistance Protein 1 (MRP1, ABCC1): Past, Present, and Future
Cole, S. P. C. (2014) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-011613-135959 · Cited by 309
Pusztai, L., Wagner, P., Ibrahim, N., Rivera, E., Theriault, R., Booser, D., Symmans, F. W., Wong, F., Blumenschein, G., Fleming, D. R., et al. (2005) · Cancer · doi:10.1002/cncr.21227 · Cited by 302
Huls, M., Brown, C. D. A., Windass, A. S., Sayer, R., van den Heuvel, J. J. M. W., Heemskerk, S., Russel, F. G. M., & Masereeuw, R. (2008) · Kidney International · doi:10.1038/sj.ki.5002645 · Cited by 293
Multidrug resistance proteins (MRPs/ABCCs) in cancer chemotherapy and genetic diseases
Chen, Z., & Tiwari, A. K. (2011) · The FEBS Journal · doi:10.1111/j.1742-4658.2011.08235.x · Cited by 274
Albermann, N., Schmitz-Winnenthal, F. H., Z’graggen, K., Volk, C., Hoffmann, M. M., Haefeli, W. E., & Weiss, J. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.06.018 · Cited by 270
Bioavailability and Pharmacokinetics of Genistein: Mechanistic Studies on its ADME
Yang, Z., Kulkarni, K., Zhu, W., & Hu, M. (2012) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152012803833107 · Cited by 270
Development of inhibitors of ATP-binding cassette drug transporters – present status and challenges
Shukla, S., Wu, C.-P., & Ambudkar, S. V. (2008) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.4.2.205 · Cited by 253
Different strategies to overcome multidrug resistance in cancer
Saraswathy, M., & Gong, S. (2013) · Biotechnology Advances · doi:10.1016/j.biotechadv.2013.06.004 · Cited by 248
Zhitomirsky, B., & Assaraf, Y. G. (2015) · Oncotarget · doi:10.18632/oncotarget.2732 · Cited by 225
Structure and function of ABC transporters: the ATP switch provides flexible control
Linton, K. J., & Higgins, C. F. (2007) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-006-0126-x · Cited by 220
Mechanisms of Chemotherapeutic Drug Resistance in Cancer Therapy—A Quick Review
Liu, F.-S. (2009) · Taiwanese Journal of Obstetrics and Gynecology · doi:10.1016/s1028-4559(09)60296-5 · Cited by 220
Inhibition of P-Glycoprotein Function and Expression by Kaempferol and Quercetin
Limtrakul, P., Khantamat, O., & Pintha, K. (2005) · Journal of Chemotherapy · doi:10.1179/joc.2005.17.1.86 · Cited by 210
Szakács, G., Hall, M. D., Gottesman, M. M., Boumendjel, A., Kachadourian, R., Day, B. J., Baubichon-Cortay, H., & Di Pietro, A. (2014) · Chemical Reviews · doi:10.1021/cr4006236 · Cited by 203
Multidrug Resistance Proteins (MRPs) and Cancer Therapy
Zhang, Y.-K., Wang, Y.-J., Gupta, P., & Chen, Z.-S. (2015) · The AAPS Journal · doi:10.1208/s12248-015-9757-1 · Cited by 196
Effect of quercetin on hoechst 33342 transport by purified and reconstituted p-glycoprotein
Shapiro, A. B., & Ling, V. (1997) · Biochemical Pharmacology · doi:10.1016/s0006-2952(96)00826-x · Cited by 194
Cellular Redox Pathways as a Therapeutic Target in the Treatment of Cancer
Montero, A. J., & Jassem, J. (2011) · Drugs · doi:10.2165/11592590-000000000-00000 · Cited by 194
Pick, A., Müller, H., Mayer, R., Haenisch, B., Pajeva, I. K., Weigt, M., Bönisch, H., Müller, C. E., & Wiese, M. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2010.12.043 · Cited by 192
Dantzig, A. H., Shepard, R. L., Law, K. L., Tabas, L., Pratt, S., Gillespie, J. S., Binkley, S. N., Kuhfeld, M. T., Starling, J. J., & Wrighton, S. A. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)34974-2 · Cited by 179
Sinha, B. K., & Mimnaugh, E. G. (1990) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(90)90155-c · Cited by 172
Minderman, H., O’Loughlin, K. L., Pendyala, L., & Baer, M. R. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0914-3 · Cited by 170
Nanotechnology approaches for personalized treatment of multidrug resistant cancers
Minko, T., Rodríguez-Rodríguez, L., & Pozharov, V. P. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.09.017 · Cited by 169
Kwak, E. L., Ahronian, L. G., Siravegna, G., Mussolin, B., Borger, D. R., Godfrey, J. T., Jessop, N. A., Clark, J. W., Blaszkowsky, L. S., Ryan, D. P., et al. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0748 · Cited by 169
Li, G. (2010) · International Journal of Oncology · doi:10.3892/ijo_00000659 · Cited by 168
Boumendjel, A., Di Pietro, A., Dumontet, C., & Barron, D. (2002) · Medicinal Research Reviews · doi:10.1002/med.10015 · Cited by 162
ABCC2/Abcc2: a multispecific transporter with dominant excretory functions
Jemnitz, K., Herédi‐Szabó, K., Jánossy, J., Ioja, E., Vereczkey, L., & Krajcsi, P. (2010) · Drug Metabolism Reviews · doi:10.3109/03602530903491741 · Cited by 152
Liang, G., Tang, A., Lin, X., et al. (2010) · PubMed · Cited by 150
El-Readi, M. Z., Hamdan, D. I., Farrag, N. M., El-Shazly, A. M., & Wink, M. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.09.040 · Cited by 150
The therapeutic potential of targeting ABC transporters to combat multi-drug resistance
Bugde, P., Biswas, R., Mérien, F., Lu, J., Liu, D., Chen, M., Zhou, S., & Li, Y. (2017) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2017.1310841 · Cited by 147
Characterization of tetrandrine, a potent inhibitor of P-glycoprotein-mediated multidrug resistance
Fu, L., Liang, Y.-J., Deng, L., Ding, Y. P., Chen, L., Ye, Y.-L., Yang, X., & Pan, Q. (2004) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-003-0742-5 · Cited by 145
Cellular Models and In Vitro Assays for the Screening of modulators of P-gp, MRP1 and BCRP
Gameiro, M., Silva, R. V. D. S., Rocha‐Pereira, C., Carmo, H., Carvalho, F. D., Bastos, M. D. L., & Remião, F. (2017) · Molecules · doi:10.3390/molecules22040600 · Cited by 144
Multi-Drug Resistance in Cancer
(2009) · Methods in molecular biology · doi:10.1007/978-1-60761-416-6 · Cited by 142
A High-Throughput Cell-Based Assay for Inhibitors of ABCG2 Activity
Henrich, C. J., Bokesch, H. R., Dean, M. C., Bates, S. E., Robey, R. W., Goncharova, E. I., Wilson, J. A., & McMahon, J. B. (2006) · SLAS DISCOVERY · doi:10.1177/1087057105284576 · Cited by 142
Investigational ABC transporter inhibitors
Falasca, M., & Linton, K. J. (2012) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2012.679339 · Cited by 128
In vitro effect of quercetin on human gastric carcinoma: Targeting cancer cells death and MDR
Borska, S., Chmielewska, M., Wysocka, T., Drąg‐Zalesińska, M., Zabel, M., & Dzięgiel, P. (2012) · Food and Chemical Toxicology · doi:10.1016/j.fct.2012.06.035 · Cited by 122
Chen, Z., Huang, C., Ma, T., Jiang, L., Tang, L., Shi, T., Zhang, S., Zhang, L., Zhu, P., Li, J., et al. (2018) · Phytomedicine · doi:10.1016/j.phymed.2018.03.040 · Cited by 121
Sandusky, G. E., Mintze, K., Pratt, S. E., & Dantzig, A. H. (2002) · Histopathology · doi:10.1046/j.1365-2559.2002.01403.x · Cited by 118
Actis‐Goretta, L., Lévèques, A., Rein, M. J., Teml, A., Schäfer, C., Hofmann, U., Li, H., Schwab, M. G., Eichelbaum, M. F., & Williamson, G. (2013) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.113.065789 · Cited by 114
Aplidin, a Marine Organism–Derived Compound with Potent Antimyeloma Activity In vitro and In vivo
Mitsiades, C. S., Ocio, E. M., Pandiella, A., Maiso, P., Gajate, C., Garayoa, M., Vilanova, D., Montero, J. C., Mitsiades, N., McMullan, C. J., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5725 · Cited by 112
Free radicals in anticancer drug pharmacology
Sinha, B. K. (1989) · Chemico-Biological Interactions · doi:10.1016/0009-2797(89)90117-8 · Cited by 107
Inhibition of anticancer drug efflux transporter P-glycoprotein by rosemary phytochemicals
Nabekura, T., Yamaki, T., Hiroi, T., Ueno, K., & Kitagawa, S. (2009) · Pharmacological Research · doi:10.1016/j.phrs.2009.11.010 · Cited by 101
Tidefelt, U., Liliemark, J. O., Gruber, A., Liliemark, E., Sundman‐Engberg, B., Juliusson, G., Stenke, L., Elmhorn‐Rosenborg, A., Möllgård, L., Lehman, S., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.9.1837 · Cited by 100
Hu, T., To, K. K. W., Wang, L., Zhang, L., Lu, L., Shen, J., Chan, R. L. Y., Li, M., Yeung, J. H. K., & Cho, C. H. (2014) · Phytomedicine · doi:10.1016/j.phymed.2014.06.013 · Cited by 99
Tetrandrine induces apoptosis and growth suppression of colon cancer cells in mice
Wu, J., Chen, Y., Chen, J.-C., et al. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.06.009 · Cited by 98
Kemper, E. M., Cleypool, C. G. J., Boogerd, W. J., Beijnen, J. H., & van Tellingen, O. (2003) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-003-0720-y · Cited by 97
Yu, C., Wu, P., Hou, Y., Lin, S.-P., Tsai, S.-Y., Chen, C., & Chao, P.-D. L. (2011) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf104786t · Cited by 95
Bates, S. E., Shieh, C.-Y., Mickley, L. A., Dichek, H. L., Gazdar, A. F., Loriaux, D. L., & Fojo, A. T. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-73-1-18 · Cited by 94
Wilson, W. H., Jamis‐Dow, C., Bryant, G., Balis, F. M., Klecker, R. W., Bates, S. E., Chabner, B. A., Steinberg, S. M., Köhler, D., & Wittes, R. E. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.8.1985 · Cited by 94
Taxane resistance in castration-resistant prostate cancer: mechanisms and therapeutic strategies
Bumbaca, B., & Li, W. (2018) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2018.04.007 · Cited by 90
Structure and function of BCRP, a broad specificity transporter of xenobiotics and endobiotics
Jani, M., Temesszentandrási‐Ambrus, C., Magnan, R., Jakab, K. T., Beéry, E., Zolnerciks, J. K., & Krajcsi, P. (2014) · Archives of Toxicology · doi:10.1007/s00204-014-1224-8 · Cited by 86
Circumvention of multi-drug resistance of cancer cells by Chinese herbal medicines
Chai, S., To, K. K. W., & Lin, G. (2010) · Chinese Medicine · doi:10.1186/1749-8546-5-26 · Cited by 80
Huang, X., Xiao, X., Zhang, Y., Talele, T. T., Salim, A. A., Chen, Z., & Capon, R. J. (2014) · Marine Drugs · doi:10.3390/md12073818 · Cited by 79
QSAR analysis and molecular modeling of ABCG2-specific inhibitors
Nicolle, E., Boumendjel, A., Macalou, S., Genoux‐Bastide, E., Ahmed‐Belkacem, A., Carrupt, P., & Pietro, A. D. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.10.004 · Cited by 77
Antitumor activity of terpenoids against classical and atypical multidrug resistant cancer cells
Lage, H., Duarte, N., Coburger, C., Hilgeroth, A., & Ferreira, M. U. (2009) · Phytomedicine · doi:10.1016/j.phymed.2009.07.009 · Cited by 77
SUN, L., Chen, W., Qu, L., Wu, J., & Jin, S. (2013) · Molecular Medicine Reports · doi:10.3892/mmr.2013.1742 · Cited by 77
Defeating drug resistance in cancer.
Gottesman, M. M., Ludwig, J. A., Xia, D., & Szakács, G. (2006) · PubMed · Cited by 76
Ma, Y., & Wink, M. (2008) · Phytomedicine · doi:10.1016/j.phymed.2007.11.028 · Cited by 75
Lei, Y., Tan, J., Wink, M., Ma, Y., Li, N., & Su, G. (2012) · Food Chemistry · doi:10.1016/j.foodchem.2012.09.059 · Cited by 70
New insights in the biology of ABC transporters ABCC2 and ABCC3: impact on drug disposition
van der Schoor, L. W. E., Verkade, H. J., Kuipers, F., & Jonker, J. W. (2014) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2015.981152 · Cited by 69
Sun, J., Yeung, C. A., Co, N. N., Tsang, T. Y., Yau, E., Luo, K.-W., Wu, P., Chan, J. Y., Fung, K., Kwok, T. T., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040720 · Cited by 69
Current Status on Marine Products with Reversal Effect on Cancer Multidrug Resistance
Abraham, I., Sayed, K. A. E., Chen, Z., & Guo, H. (2012) · Marine Drugs · doi:10.3390/md10102312 · Cited by 68
Luurtsema, G., Schuit, R. C., Klok, R. P., Verbeek, J., Leysen, J. E., Lammertsma, A. A., & Windhorst, A. D. (2009) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2009.03.004 · Cited by 66
Wesołowska, O., Wiśniewski, J. Ł., Środa-Pomianek, K., Bielawska‐Pohl, A., Paprocka, M., Duś, D., Duarte, N., Ferreira, M. U., & Michalak, K. (2012) · Journal of Natural Products · doi:10.1021/np3003468 · Cited by 65
Abraham, I., Jain, S. K., Wu, C., Khanfar, M. A., Kuang, Y., Dai, C.-L., Shi, Z., Chen, X., Fu, L., Ambudkar, S. V., et al. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.08.001 · Cited by 64
Banuls, L. M. Y., Urban, E., Gelbcke, M., Dufrasne, F., Kopp, B., Robert Kiss, A., & Zehl, M. (2013) · Journal of Natural Products · doi:10.1021/np400034d · Cited by 63
Kim, M. K., Choo, H., & Chong, Y. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm500290c · Cited by 63
Absorption and Metabolism Characteristics of Rutin in Caco‐2 Cells
Zhang, X., Song, J., Shi, X., Miao, S., Li, Y., & Wen, A. (2013) · The Scientific World JOURNAL · doi:10.1155/2013/382350 · Cited by 62
Eribulin mesylate: A novel halichondrin B analogue for the treatment of metastatic breast cancer
McBride, A., & Butler, S. K. (2012) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp110237 · Cited by 62
Li, C., Kim, M.-H., Choi, H.-S., & Choi, J. (2011) · Archives of Pharmacal Research · doi:10.1007/s12272-011-1117-9 · Cited by 60
Jain, S. K., Abraham, I., de Carvalho, P. B., Kuang, Y., Shaala, L. A., Youssef, D. T. A., Avery, M. A., Chen, Z., & Sayed, K. A. E. (2009) · Journal of Natural Products · doi:10.1021/np900091y · Cited by 56
Nabekura, T., Yamaki, T., & Kitagawa, S. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.10.025 · Cited by 56
Shi, L.-X., Ma, R., Lu, R., Xu, Q., Zhu, Z., Wang, L., Zhou, C., Li, X., Zhang, H., & Yao, Z. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.04.033 · Cited by 55
Disposition of Flavonoids Impacts their Efficacy and Safety
Ma, Y., Zeng, M., Sun, R., & Hu, M. (2015) · Current Drug Metabolism · doi:10.2174/1389200216666150206123719 · Cited by 55
Du, J., He, Y., Li, P., Wu, W., Chen, Y., & Ruan, H. (2018) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-018-3584-x · Cited by 52
Marine Natural Products as Breast Cancer Resistance Protein Inhibitors
Chérigo, L., Lopéz, D., & Martínez‐Luis, S. (2015) · Marine Drugs · doi:10.3390/md13042010 · Cited by 51
To, K. K. W., Wu, X., Yin, C., Chai, S., Yao, S., Kadioglu, O., Efferth, T., Ye, Y., & Lin, G. (2017) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2017.03.051 · Cited by 51
Berbamine exhibits potent antitumor effects on imatinib-resistant CML cells in vitro and in vivo
Wei, Y., Xu, L., Liang, Y., Xu, X., & Zhao, X. (2009) · Acta Pharmacologica Sinica · doi:10.1038/aps.2009.19 · Cited by 50
Kadioglu, O., Saeed, M. E. M., Valoti, M., Frosini, M., Sgaragli, G., & Efferth, T. (2016) · Biochemical Pharmacology · doi:10.1016/j.bcp.2016.01.014 · Cited by 49
Tenacigenin B Derivatives Reverse P-Glycoprotein-Mediated Multidrug Resistance inHepG2/Dox Cells
Hu, Y., Shen, X., Lu, H.-L., et al. (2008) · Journal of Natural Products · doi:10.1021/np070458f · Cited by 48
Li, Y., Fan, L., Sun, Y., Miao, X., Zhang, F., Meng, J., Han, J., Zhang, D., Zhang, R., Yue, Z., et al. (2014) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2014.04.049 · Cited by 47
Jiang, M., Zhang, R., Wang, Y., Jing, W., Liu, Y., Ma, Y., Sun, B., Wang, M., Chen, P., Liu, H., et al. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b00381 · Cited by 47
The use of proteomic technologies to study molecular mechanisms of multidrug resistance in cancer
Cao, Y., Li, Z., Mao, L., Cao, H., Kong, J., Yu, B., Yu, C., & Liao, W. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.10.001 · Cited by 47
CHEN, F.-Y., CAO, L.-F., Wan, H., Zhang, M. L., CAI, J.-Y., Shen, L., ZHONG, J.-H., & Zhong, H. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2734 · Cited by 46
Sandeep, M. S., Vemulapalli, S., Puneeth, Y., Pingili, R. B., & Babu, K. N. (2013) · Drug Development and Industrial Pharmacy · doi:10.3109/03639045.2013.819885 · Cited by 43
Wei, N., Liu, G.-T., Chen, X., Liu, Q., Wang, F., & Sun, H. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.08.012 · Cited by 43
Lee, E., Enomoto, R., Koshiba, C., & Hirano, H. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04722.x · Cited by 43
Zhou, X., Li, D., Wang, X., Zhang, B., Zhu, H., & Zhao, J. (2014) · Oncotarget · doi:10.18632/oncotarget.3076 · Cited by 41
Marine Natural Products as Models to Circumvent Multidrug Resistance
Long, S., Sousa, E., Kijjoa, A., & Pinto, M. M. M. (2016) · Molecules · doi:10.3390/molecules21070892 · Cited by 41
Identification of new P-glycoprotein inhibitors derived from cardiotonic steroids
Zeino, M., Paulsen, M. S., Zehl, M., Urban, E., Kopp, B., & Efferth, T. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.10.009 · Cited by 38
Hesselson, S., Matsson, P., Shima, J. E., Fukushima, H., Yee, S. W., Kobayashi, Y., Gow, J. M., Ha, C. W. Y., Ma, B., Poon, A., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006942 · Cited by 38
Synthesis and evaluation of Strychnos alkaloids as MDR reversal agents for cancer cell eradication
Munagala, S., Sirasani, G., Kokkonda, P., Phadke, M. A., Krynetskaia, N. F., Lu, P., Sharom, F. J., Chaudhury, S., AbdulHameed, M. D. M., Tawa, G. J., et al. (2013) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2013.12.022 · Cited by 36
Role of Piperine in Chemoresistance
Kumar, S., Bhandari, C., Sharma, P., & Agnihotri, N. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-812373-7.00013-9 · Cited by 31
Effects of kaempferol on the mechanisms of drug resistance in the human glioblastoma cell line T98G
Nakatsuma, A., Fukami, T., Suzuki, T., Furuishi, T., Tomono, K., & Hidaka, S. (2010) · Die Pharmazie · doi:10.31083/ph.2010.9807 · Cited by 29
Hsiao, S.-H., Lin, Y.-J., Yang, C.-C., Tuo, W.-C., Li, Y., Huang, Y.-H., Hsieh, C., Hung, T., & Wu, C. (2016) · Journal of Natural Products · doi:10.1021/acs.jnatprod.6b00597 · Cited by 29
Triterpenoids from Momordica balsamina: Reversal of ABCB1-mediated multidrug resistance
Ramalhete, C., Mulhovo, S., Molnar, J. A., & Ferreira, M. U. (2016) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2016.08.022 · Cited by 29
Fu, Q., Kang, K. W., & Han, H. (2012) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.1811 · Cited by 27
Wen, Y., Zhao, R.-Q., Gupta, P., Fan, Y., Zhang, Y., Huang, Z., Li, X., Su, Y., Liao, L., Xie, Y.-A., et al. (2018) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2018.10.001 · Cited by 26
Condello, M., Cosentino, D., Corinti, S., Felice, G. D., Multari, G., Gallo, F. R., Arancia, G., & Meschini, S. (2014) · Journal of Natural Products · doi:10.1021/np400950h · Cited by 25
Cytotoxic Dimeric Epipolythiodiketopiperazines from the Ascomycetous Fungus Preussia typharum
Du, L., Robles, A. J., King, J. B., Mooberry, S. L., & Cichewicz, R. H. (2014) · Journal of Natural Products · doi:10.1021/np5002253 · Cited by 24
Gupta, V. K., Bhalla, Y., & Jaitak, V. (2013) · Medicinal Chemistry Research · doi:10.1007/s00044-013-0612-6 · Cited by 23
Self-citationChang, L., Xiao, M., Yang, L., et al. (2018) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2018.08.021 · Cited by 23
Esters of the Marine-Derived Triterpene Sipholenol A Reverse P-GP-Mediated Drug Resistance
Zhang, Y., Zhang, Y., Wang, Y., Vispute, S. G., Jain, S. K., Chen, Y., Li, J., Youssef, D. T. A., Sayed, K. A. E., & Chen, Z. (2015) · Marine Drugs · doi:10.3390/md13042267 · Cited by 22
Zhang, H., Chen, Y., & Tang, Y. (2014) · Chemistry & Biodiversity · doi:10.1002/cbdv.201300220 · Cited by 21
Dačević, M., Isaković, A., Podolski-Renić, A., Isakovic, A. M., Stanković, T., Milosevic, Z. C., Rakić, L., Ruždijić, S., & Pešić, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054044 · Cited by 21
Cited by
Improvement of conventional anti-cancer drugs as new tools against multidrug resistant tumors
Dallavalle, S., Dobričić, V., Lazzarato, L., Gazzano, E., Machuqueiro, M., Pajeva, I., Tsakovska, I., Zidar, N., & Fruttero, R. (2020) · Drug Resistance Updates · doi:10.1016/j.drup.2020.100682 · Cited by 318
Zhang, H., Xu, H., Ashby, C. R., Assaraf, Y. G., Chen, Z., & Liu, H. (2021) · Medicinal Research Reviews · doi:10.1002/med.21739 · Cited by 270
Clinically-Relevant ABC Transporter for Anti-Cancer Drug Resistance
Xiao, H., Zheng, Y., Ma, L., Tian, L., & Sun, Q. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.648407 · Cited by 263
Medicinal chemistry strategies to discover P-glycoprotein inhibitors: An update
Dong, J., Qin, Z., Zhang, W.-D., Cheng, G., Yehuda, A. G., Ashby, C. R., Chen, Z.-S., Cheng, X.-D., & Qin, J.-J. (2020) · Drug Resistance Updates · doi:10.1016/j.drup.2020.100681 · Cited by 255
Metadata
- Authors
- Kumar, A., & Jaitak, V.
- Venue
- European Journal of Medicinal Chemistry
- Publisher
- Elsevier BV
- Published
- 2019-08
- Volume
- 176
- Pages
- 268-291
- ISSN
- 0223-5234 (ISSN-L)
- OpenAlex
- W2944725533
- Cited by
- 334
- References
- 151
- FWCI
- 15.42
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.